Substances that trigger prolonged immune responses contribute to the development of atherosclerosis. An EU-funded project is identifying these substances and the underlying mechanisms involved, opening the door to new management strategies for chronic inflammatory diseases.

Source: Research Information Centre
New therapeutic potential for chronic inflammatory diseases